Cancer Epidemiology, Biomarkers & Prevention

Among the stage M0 patients, 78.9% of them (n=254) had infiltrating ductal carcinoma, 50.6% (n=163) had T3-4 disease, 68.3% (n=220) had poorly/undifferentiated disease, 66.1% (n=213) had HER2 … ................
................

In order to avoid copyright disputes, this page is only a partial summary.